Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and Depressive Disorder, Major

methoxyhydroxyphenylglycol has been researched along with Depressive Disorder, Major in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.00)18.7374
1990's0 (0.00)18.2507
2000's8 (40.00)29.6817
2010's9 (45.00)24.3611
2020's2 (10.00)2.80

Authors

AuthorsStudies
Cai, H; Cao, T; Chen, Q; Jiao, S; Wang, L; Wu, X; Yang, C; Yang, D; Yang, P; Zeng, C; Zhang, S; Zhu, Z1
Igata, R; Ikenouchi, A; Natsuyama, T; Okamoto, N; Yoshimura, R1
Forman, J; Kessing, LV; Knorr, U; Pech, J1
Kunugi, H; Ogawa, S; Tsuchimine, S1
Cubała, WJ; Czarnowski, W; Landowski, J; Wielgomas, B1
Boldrini, M; Cooper, TB; Currier, D; Ellis, SP; Malone, KM; Mann, JJ; Oquendo, MA; Sullivan, G; Watson, KT; Xie, S1
Currier, D; Galfalvy, H; Huang, YY; Mann, JJ; Oquendo, MA1
Currier, D; Galfalvy, H; Huang, YY; John Mann, J; Oquendo, MA; Sullivan, G1
Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Otani, K; Suzuki, A; Ueda, N; Umene-Nakano, W; Yoshimura, R1
Granérus, AK; Mårtensson, B; Pålhagen, S; Qi, H; Svenningsson, P; Wålinder, J1
Castro, WL; Delgado, PL; El Khoury, A; Mathé, AA; Misiaszek, J; Moreno, FA; Palmer, C; Parkinson, D; Wright, R1
Atake, K; Katsuki, A; Nakamura, J; Tokutsu, Y; Umene-Nakano, W; Yoshimura, R1
Egami, M; Imamura, Y; Mizoguchi, Y; Nabeta, H; Yamada, S1
Nakamura, J; Shinkai, K; Ueda, N; Yoshimura, R1
Lima, L; Manzano, E; Mata, S; Ortiz, T; Urbina, M1
Nakamura, J; Ueda, N; Yoshimura, R; Yukimasa, T1
Brent, D; Currier, D; Galfalvy, H; Greenhill, L; Huang, YY; Mann, JJ; Murphy, L; Oquendo, M1
Hori, H; Mitoma, M; Miyamoto, K; Nakamura, J; Sugita, A; Ueda, N; Umene, W; Yoshimura, R1
Ellis, SP; Huang, YY; Malone, KM; Mann, JJ; Oquendo, MA; Placidi, GP1
Besio, G; Loeb, C; Roccatagliatà, G1

Reviews

2 review(s) available for methoxyhydroxyphenylglycol and Depressive Disorder, Major

ArticleYear
Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies.
    Journal of affective disorders, 2018, Volume: 240

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Young Adult

2018
Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
    Journal of psychiatric research, 2018, Volume: 105

    Topics: Biomarkers; Depressive Disorder, Major; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol

2018

Trials

4 trial(s) available for methoxyhydroxyphenylglycol and Depressive Disorder, Major

ArticleYear
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Severity of Illness Index; Treatment Outcome; Young Adult

2010
CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:1

    Topics: Adult; Analysis of Variance; Case-Control Studies; Chromatography, High Pressure Liquid; Circadian Rhythm; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Electrochemistry; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Indoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurochemistry; Neuropeptide Y; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Tryptophan; Young Adult

2010
Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression.
    Pharmacopsychiatry, 2002, Volume: 35, Issue:5

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Depressive Disorder, Major; Dopamine Antagonists; Female; Fluvoxamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sulpiride; Treatment Outcome

2002
Effects of acute paroxetine treatment on the consumption of cigarette smoking and caffeine in depressed patients.
    Human psychopharmacology, 2007, Volume: 22, Issue:7

    Topics: Adult; Aged; Caffeine; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cotinine; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Smoking; Tobacco Use Disorder; Treatment Outcome

2007

Other Studies

14 other study(ies) available for methoxyhydroxyphenylglycol and Depressive Disorder, Major

ArticleYear
Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.
    European archives of psychiatry and clinical neuroscience, 2022, Volume: 272, Issue:7

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adolescent; Adult; Biomarkers; Depressive Disorder, Major; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Serotonin; Tryptophan; Vanilmandelic Acid

2022
The Molecular Mechanism of Exercise for Treatment of Patients with Major Depression: A Preliminary Report on the Dynamics of Metabolites of Nitric Oxide and Catecholamines.
    Journal of integrative neuroscience, 2022, Jun-30, Volume: 21, Issue:4

    Topics: Catecholamines; Depression; Depressive Disorder, Major; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Nitric Oxide

2022
Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
    Journal of affective disorders, 2014, Volume: 161

    Topics: Adult; Case-Control Studies; Cross-Sectional Studies; Depressive Disorder, Major; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Receptors, Adrenergic; Saliva; Young Adult

2014
Anxiety in major depression and cerebrospinal fluid free gamma-aminobutyric acid.
    Depression and anxiety, 2014, Volume: 31, Issue:10

    Topics: Adult; Age Factors; Anxiety; Bipolar Disorder; Case-Control Studies; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Severity of Illness Index; Young Adult

2014
Increased risk of suicide attempt in mood disorders and TPH1 genotype.
    Journal of affective disorders, 2009, Volume: 115, Issue:3

    Topics: Adolescent; Adult; Aged; Bipolar Disorder; Black or African American; Depressive Disorder, Major; Female; Genetic Predisposition to Disease; Haplotypes; Hispanic or Latino; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Mood Disorders; New York; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Sex Factors; Suicide, Attempted; Tryptophan Hydroxylase; White People; Young Adult

2009
Lower CSF MHPG predicts short-term risk for suicide attempt.
    The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:10

    Topics: Adult; Biomarkers; Bipolar Disorder; Cohort Studies; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Factors; Suicide, Attempted; Time Factors

2009
Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression.
    Journal of neurology, 2010, Volume: 257, Issue:4

    Topics: Aged; Analysis of Variance; Biogenic Monoamines; Brain-Derived Neurotrophic Factor; Corticosterone; Depressive Disorder, Major; Enzyme-Linked Immunosorbent Assay; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Interleukin-6; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Radioimmunoassay

2010
The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy.
    The journal of ECT, 2012, Volume: 28, Issue:1

    Topics: Depressive Disorder, Major; Electroconvulsive Therapy; Ethylene Glycols; Homovanillic Acid; Humans; Hyperprolactinemia; Male; Methoxyhydroxyphenylglycol; Middle Aged; Phenols; Psychiatric Status Rating Scales

2012
Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
    Human psychopharmacology, 2013, Volume: 28, Issue:1

    Topics: Adult; Aged; Biomarkers; Depressive Disorder, Major; Female; Humans; Male; Methoxyhydroxyphenylglycol; Mianserin; Middle Aged; Mirtazapine; Saliva; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2013
Noradrenaline transporter and its turnover rate are decreased in blood lymphocytes of patients with major depression.
    Journal of neuroimmunology, 2005, Dec-30, Volume: 170, Issue:1-2

    Topics: Adult; Blood Platelets; Cell Membrane; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Lymphocytes; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Serotonin

2005
[Therapeutic effectiveness of transcranial magnetic stimulation for intractable depressive disorders-- blood catecholamines and BDNF].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2007, Volume: 109, Issue:4

    Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Transcranial Magnetic Stimulation

2007
No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover.
    Journal of affective disorders, 2008, Volume: 106, Issue:1-2

    Topics: Adult; Bipolar Disorder; Child; Child Abuse; Depressive Disorder, Major; Female; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Personality Inventory; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Suicide, Attempted; Tryptophan Hydroxylase

2008
Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels.
    Biological psychiatry, 2001, Nov-15, Volume: 50, Issue:10

    Topics: Adult; Aggression; Depressive Disorder, Major; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Suicide, Attempted

2001
[Variations in the urinary level of MHPG in depressive syndromes].
    Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie, 1979, Volume: 125, Issue:2

    Topics: Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Anxiety; Depression; Depressive Disorder; Depressive Disorder, Major; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Perphenazine; Recurrence; Trazodone; Viloxazine

1979